2
Participants
Start Date
June 30, 2020
Primary Completion Date
February 2, 2021
Study Completion Date
February 2, 2021
Venetoclax
Tablet: Oral
Pembrolizumab
Intravenous (IV) Infusion
Weill Cornell Medical Center /ID# 216911, New York
Allegheny General Hospital /ID# 214363, Pittsburgh
Virginia Cancer Specialists /ID# 214328, Fairfax
Massey Cancer Centre /ID# 212527, Richmond
Georgia Regents University /ID# 217109, Augusta
AdventHealth Cancer Institute - Orlando /ID# 214444, Orlando
Univ of Alabama at Birmingham /ID# 214180, Birmingham
Thompson Cancer Survival Ctr /ID# 217076, Knoxville
University of Louisville /ID# 215195, Louisville
Ashland-Bellefonte Cancer Ctr /ID# 218511, Ashland
University Hospitals Cleveland /ID# 212241, Cleveland
Fort Wayne Medical Oncology /ID# 214954, Fort Wayne
Karmanos Cancer Institute /ID# 216986, Detroit
Henry Ford Health System /ID# 216385, Detroit
Ingalls Memorial Hosp /ID# 214952, Harvey
Rush University Medical Center /ID# 212448, Chicago
Washington University-School of Medicine /ID# 212355, St Louis
Houston Methodist Hospital - Scurlock Tower /ID# 215481, Houston
Utah Cancer Specialists /ID# 215496, Salt Lake City
Arizona Oncology Associates, PC-HOPE (Rudasill) /ID# 216984, Tucson
Icri /Id# 217071, Whittier
St Jude Hospital dba St Joseph /ID# 212360, Santa Rosa
Providence Cancer Center Oncology and Hematology Care - Westside Portland /ID# 215497, Portland
Multicare Institute for Research and Innovation /ID# 217913, Tacoma
Northwest Medical Specialties /ID# 218484, Tacoma
University of Chicago DCAM /ID# 214319, Chicago
Central Maine Medical Center /ID# 216107, Lewiston
Maryland Oncology Hematology /ID# 214131, Columbia
University of Massachusetts Ca /ID# 218744, Worcester
Univ of Mississippi Med Ctr /ID# 216429, Jackson
Methodist Estabrook Cancer Center /ID# 216910, Omaha
University of Nebraska Medical Center /ID# 216754, Omaha
Hackensack Univ Med Ctr /ID# 216484, Hackensack
Atlantic Health System /ID# 217067, Morristown
Overlook Medical Center /ID# 219108, Summit
NYU Langone - Laura and Isaac Perlmutter Cancer Center /ID# 218077, New York
University of Cincinnati Cancer Institute /ID# 216800, Cincinnati
The Ohio State University - The James /ID# 212298, Columbus
Prisma Health Cancer Institute - Faris /ID# 217946, Greenville
Lead Sponsor
AbbVie
INDUSTRY